QRG Capital Management Inc. Makes New $547,000 Investment in Astera Labs, Inc. $ALAB

QRG Capital Management Inc. bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,048 shares of the company’s stock, valued at approximately $547,000.

A number of other institutional investors also recently bought and sold shares of ALAB. Alliancebernstein L.P. boosted its position in Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after purchasing an additional 4,478,741 shares in the last quarter. Atreides Management LP boosted its position in Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after purchasing an additional 2,815,614 shares in the last quarter. FengHe Fund Management Pte. Ltd. purchased a new stake in Astera Labs during the second quarter worth $106,772,000. Bank of Nova Scotia boosted its position in Astera Labs by 3,742.2% during the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company’s stock worth $57,546,000 after purchasing an additional 939,300 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in shares of Astera Labs in the first quarter valued at $32,998,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several recent research reports. TD Cowen initiated coverage on Astera Labs in a research report on Wednesday, October 1st. They issued a “hold” rating and a $200.00 price objective on the stock. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective on the stock. in a research report on Tuesday, July 22nd. Barclays restated an “overweight” rating and issued a $155.00 price objective (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the company a “buy” rating in a research report on Monday, August 4th. Finally, Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Fifteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $159.83.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the transaction, the chief operating officer owned 5,525,545 shares of the company’s stock, valued at $939,453,160.90. This trade represents a 4.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the transaction, the chief financial officer directly owned 518,996 shares in the company, valued at approximately $88,945,534.48. This represents a 16.16% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,308,772 shares of company stock worth $214,482,678. Company insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

ALAB stock opened at $206.21 on Friday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market cap of $34.28 billion, a P/E ratio of 368.23, a price-to-earnings-growth ratio of 5.62 and a beta of 1.43. The stock has a 50-day simple moving average of $198.72 and a 200-day simple moving average of $124.17.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter last year, the firm earned $0.13 earnings per share. The company’s revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.